LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway

Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

(2019) Ma-Sha Huang et al.   Frontiers in Oncology

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression

(2018) Kentaro Inamura   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Unknown

(2018)   JOURNAL OF CELLULAR BIOCHEMISTRY

Unknown

(2018)   MOLECULAR CARCINOGENESIS

Cell death-based treatment of lung adenocarcinoma

(2018) Tatiana V. Denisenko et al.   Cell Death & Disease

The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway

(2018) Feng Guo et al.   Experimental and Therapeutic Medicine

LncRNA ATB promotes the proliferation and metastasis of lung cancer via activation of the p38 signaling pathway

(2018) Lei Wei et al.   Oncology Letters

The Function and Mechanism of Long Non-coding RNA-ATB in Cancers

(2018) Huizhong Xiao et al.   Frontiers in Physiology

LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis

(2017) Na Fu et al.   GENE

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner

(2017) Xiaobing Qin et al.   International Journal of Nanomedicine

Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling

(2017) Georg Emons et al.   MOLECULAR CANCER RESEARCH

Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis

(2017) Bangli Hu et al.   Biomed Research International

Highlights in the Treatment of Lung Cancer

(2017) Martin J. Edelman   JAMA Oncology

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer

(2016) L. Ke et al.   Clinical & Translational Oncology

Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a

(2016) Chun-Chun Ma et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Unknown

(2016)   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival

(2016) Chun-Hua Dai et al.   Oncotarget

Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities

(2016) Thomas Bilfinger et al.   MEDICAL SCIENCE MONITOR

Lung cancer: Biology and treatment options

(2015) Hassan Lemjabbar-Alaoui et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Evidence for tankyrases as antineoplastic targets in lung cancer

(2013) Alexander M Busch et al.   BMC CANCER

A Strategy to Model Nonmonotonic Dose-Response Curve and Estimate IC50

(2013) Hui Zhang et al.   PLoS One

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL